Dr. Summer Lea Allen, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 4500 13th St, Gulfport, MS 39501 Phone: 228-867-4000 |
Dr. William Russell Cullinane Jr., D.O. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 15190 Community Rd Ste 110, Gulfport, MS 39503 Phone: 228-539-3356 |
News Archive
Over 700 participants plan to attend the Fifth National Summit on Women Veterans' Issues scheduled July 16-17 at the Hyatt Regency Washington on Capitol Hill. Secretary of Veterans Affairs Eric K. Shinseki will give remarks to open the summit this Saturday, which will focus on expanding outreach to women Veterans and increasing awareness of the enhanced VA benefits and services available to them.
Sleep apnea has long been known to be associated with obesity. But a new study published in the June issue of Diabetes Care finds that the disorder is widely undiagnosed among obese individuals with type 2 diabetes - nearly 87 percent of participants reported symptoms, but were never diagnosed.
The National Academy of Sports Medicine (NASM), a global leader in sports performance training and personal training certification, today announced the release of an enhanced version if its Performance Enhancement Specialist (NASM PES) course, the "NASM Essentials of Sports Performance Training."
Children who suffer from Hutchinson-Gilford Progeria syndrome age prematurely due to a defective protein in their cells. Scientists at Technische Universität München have now identified another important pathological factor: the system responsible for removing cellular debris and for breaking down defective proteins operates at lower levels in HGPS cells than in normal cells. The researchers have succeeded in reactivating protein breakdown in HGPS cells and thus reducing disease-related defects by using a substance from broccoli.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, driven primarily by the launch and widespread uptake of novel oral anticoagulants, the combined markets for drugs used in the treatment and prophylaxis of venous thromboembolism will experience robust growth, increasing from $2.9 billion in 2009 to more than $5 billion in 2019 in the United States, France, Germany, Italy, Spain, United Kingdom and Japan.
› Verified 4 days ago